Early clinical outcomes and molecular smooth muscle cell phenotyping using a prophylactic aortic arch replacement strategy in Loeys-Dietz syndrome

  • Albert J. Pedroza
  • , Paul Cheng
  • , Alex R. Dalal
  • , Kathrin Baeumler
  • , Aya Kino
  • , Emily Tognozzi
  • , Rohan Shad
  • , Nobu Yokoyama
  • , Ken Nakamura
  • , Olivia Mitchel
  • , William Hiesinger
  • , Elena Gallo MacFarlane
  • , Dominik Fleischmann
  • , Y. Joseph Woo
  • , Thomas Quertermous
  • , Michael P. Fischbein

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Objectives: Patients with Loeys-Dietz syndrome demonstrate a heightened risk of distal thoracic aortic events after valve-sparing aortic root replacement. This study assesses the clinical risks and hemodynamic consequences of a prophylactic aortic arch replacement strategy in Loeys-Dietz syndrome and characterizes smooth muscle cell phenotype in Loeys-Dietz syndrome aneurysmal and normal-sized downstream aorta. Methods: Patients with genetically confirmed Loeys-Dietz syndrome (n = 8) underwent prophylactic aortic arch replacement during valve-sparing aortic root replacement. Four-dimensional flow magnetic resonance imaging studies were performed in 4 patients with Loeys-Dietz syndrome (valve-sparing aortic root replacement + arch) and compared with patients with contemporary Marfan syndrome (valve-sparing aortic root replacement only, n = 5) and control patients (without aortopathy, n = 5). Aortic tissues from 4 patients with Loeys-Dietz syndrome and 2 organ donors were processed for anatomically segmented single-cell RNA sequencing and histologic assessment. Results: Patients with Loeys-Dietz syndrome valve-sparing aortic root replacement + arch had no deaths, major morbidity, or aortic events in a median of 2 years follow-up. Four-dimensional magnetic resonance imaging demonstrated altered flow parameters in patients with postoperative aortopathy relative to controls, but no clear deleterious changes due to arch replacement. Integrated analysis of aortic single-cell RNA sequencing data (>49,000 cells) identified a continuum of abnormal smooth muscle cell phenotypic modulation in Loeys-Dietz syndrome defined by reduced contractility and enriched extracellular matrix synthesis, adhesion receptors, and transforming growth factor-beta signaling. These modulated smooth muscle cells populated the Loeys-Dietz syndrome tunica media with gradually reduced density from the overtly aneurysmal root to the nondilated arch. Conclusions: Patients with Loeys-Dietz syndrome demonstrated excellent surgical outcomes without overt downstream flow or shear stress disturbances after concomitant valve-sparing aortic root replacement + arch operations. Abnormal smooth muscle cell–mediated aortic remodeling occurs within the normal diameter, clinically at-risk Loeys-Dietz syndrome arch segment. These initial clinical and pathophysiologic findings support concomitant arch replacement in Loeys-Dietz syndrome.

Original languageEnglish
Pages (from-to)e332-e376
JournalJournal of Thoracic and Cardiovascular Surgery
Volume166
Issue number5
DOIs
StatePublished - Nov 2023
Externally publishedYes

Keywords

  • Loeys-Dietz syndrome
  • RNA sequencing
  • aortic aneurysm
  • aortic arch
  • aortic root replacement
  • smooth muscle cell

Fingerprint

Dive into the research topics of 'Early clinical outcomes and molecular smooth muscle cell phenotyping using a prophylactic aortic arch replacement strategy in Loeys-Dietz syndrome'. Together they form a unique fingerprint.

Cite this